Home Categories API Mitotane
A7242218

Mitotane , 98% , 53-19-0

Synonym(s):
Mitotane;o,p′-DDD;(2,4′-Dichlorodiphenyl)dichloroethane;o,p′-DDD;1-(2-Chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane

CAS NO.:53-19-0

Empirical Formula: C14H10Cl4

Molecular Weight: 320.04

MDL number: MFCD00000850

EINECS: 200-166-6

Pack Size Price Stock Quantity
1g RMB112.80 In Stock
5g RMB356.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 77-78 °C(lit.)
Boiling point: 405.59°C (rough estimate)
Density  1.3118 (rough estimate)
refractive index  1.6000 (estimate)
storage temp.  Inert atmosphere,Room Temperature
solubility  DMSO: soluble20mg/mL, clear
form  powder
color  white to beige
Water Solubility  <0.1 g/100 mL at 24 ºC
Merck  13,6237 / 13,6237
BRN  2056007
InChI InChI=1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H
InChIKey JWBOIMRXGHLCPP-UHFFFAOYSA-N
SMILES C1(Cl)=CC=CC=C1C(C1=CC=C(Cl)C=C1)C(Cl)Cl

Description and Uses

Mitotane is an inhibitor of steroidogenesis that suppresses the growth of adrenocortical cells. It blocks the expression of several genes that encode proteins involved in steroidogenesis and disrupts mitochondrial respiratory chain activity in human adrenocortical cells. Mitotane has anti-neoplastic actions, alone or in combination with other compounds, and suppresses cortisol synthesis, although it also has significant toxicity in the gastrointestinal tract and nervous system. It is effective against adrenocortical carcinoma and Cushing’s Syndrome in clinical trials.

aminobiphoshphanate for treatment of osteoporosis and Paget's bone disease

Safety

Symbol(GHS) 
GHS08
Signal word  Warning
Hazard statements  H351
Precautionary statements  P280
Hazard Codes  Xn
Risk Statements  40
Safety Statements  36/37
RIDADR  3249
WGK Germany  3
RTECS  KH7880000
HazardClass  6.1(b)
PackingGroup  III
HS Code  2903990002

RELATED PRODUCTS